Jeremy Orr, MD
Critical Care Medicine · San Diego, CANPI 1992940969
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,684 of the $5,172 with a category attached, or 71.2%. Resmed Corp accounts for 75.4% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $1,821, 6.7 times the $273 reported in 2019.
Across 17 payments — averaging $304.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Resmed Corp$4K
- BD$550
- ZOLL Respicardia, Inc.$440
- Avadel CNS Pharmaceuticals, LLC$131
- Philips North America LLC$74
- Advanced Respiratory, Inc$58
- plus $19 from 1 others
Across 6 payments — averaging $2023.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Breas Medical, Inc.$12K
What the payments were for
- Consulting fees$3,68471%
- Speaking & faculty fees$76715%
- Food & beverage$72214%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Resmed Corp | 7 | $3,900 |
| BD | 1 | $550 |
| ZOLL Respicardia, Inc. | 3 | $440 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $131 |
| Philips North America LLC | 1 | $74 |
| Advanced Respiratory, Inc | 3 | $58 |
| Itamar Medical Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AirSense$2,731
- AIR 11$1,170
- BD BBL Gram Iodine (Stabilized)$550
- remede System$440
- LUMRYZ$131
How this compares
$5,172 in reported general payments places this provider in the 85th percentile of 715 critical care medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 32 | $147 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in San Diego
- Xuanha WhiteSan Diego$343K
- Praveen AkuthotaSan Diego$169K
- Wael El MaraachliSan Diego$126K
- Aarya KafiSan Diego$34K
- Anushirvan MinokadehSan Diego$33K
- Mona AlotaibiSan Diego$13K
- Jeffrey BarrySan Diego$11K
- Cedric Franklin RutlandRiverside$3.2M
- Chinh PhanSacramento$467K
- Timothy AlbertsonSacramento$418K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.